• Sabir Husain Attar Institute of Chemical Technology, N. P. Marg, Matunga
  • Dharmendra Kumar Khatri Institute of Chemical Technology, N. P. Marg, Matunga
  • Jayant Sancheti Institute of Chemical Technology, N. P. Marg, Matunga
  • Archana Ramesh Juvekar Pharmacology Research Laboratory-1, Department of Pharmaceutical Sciences and Technology (DPST), Institute of Chemical Technology, N. P. Marg, Matunga, Mumbai 400019, India


Nil, Toxicity, L-dopa, Hyoscine hydrobromide


Objective: The present study was done to evaluate repeated-dose 90-day oral toxicity studies of l-dopa and hyoscine hydrbromide combination in rats.

Methods: Repeated-dose 90-day oral toxicity study was performed according to the Organisation for Economic Co-operation and Development (OECD) guidelines 408. In the present study, combination of L-dopa and hyoscine hydrobromide was administered at 5 times the upper limit of therapeutic dose of each drug which is 1200 mg per day for L-dopa and 0.75 mg per day for hyoscine hydrobromide for adult human being and which was converted to required dose for Wistar rats (5 males and 5 females).

Results: The combination of L-dopa and hyoscine hydrobromide at 5 times the upper therapeutic dose produced no treatment-related signs of toxicity or mortality in any of the animals tested during 90 d of the study. The subchronic administration of the combination of L-dopa and hyoscine hydrobromide did not produce any significant difference in any of the assigned parameters between the control and all treatment groups.

Conclusion: It is established that the combination of L-dopa and hyoscine hydrobromide therapy is safe on repeated dose 90-day oral toxicity at 5 times the upper limit of therapeutics dose of each drug.



Download data is not yet available.


Edwards TM, Myers JP. Environmental exposures and gene regulation in disease etiology. Environ Health Perspect 2007;115:1264-70.

Serra PA, Esposito G, Enrico P, Mura MA, Migheli R, Delogu MR, et al. Manganese increases l-DOPA auto-oxidation in the striatum of the freely moving rat: potential implications to l-DOPA long-term therapy of Parkinson’s disease. Br J Pharmacol 2000;130:937-45.

Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, et al. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol 2009;8:1150-7.

Tolosa E, Marti MJ, Valldeoriola F, Molinuevo JL. History of levodopa and dopamine agonists in Parkinson’s disease treatment. Neurology 1998;50:S2-S10.

Lee PH, Park HJ. Bone marrow-derived mesenchymal stem cell therapy as a candidate disease-modifying strategy in Parkinson’s disease and multiple system atrophy. J Clin Neurol 2009;5:1-10.

Hauser RA. Levodopa: past, present, and future. Eur Neurol 2009;61:1-8.

Maharaj H, Maharaj DS, Scheepers M, Mokokong R, Daya S. l-DOPA administration enhances 6-hydroxydopamine generation. Brain Res 2005;1063:180-6.

Ostock CY, Dupre KB, Jaunarajs KL, Walters H, George J, Krolewski D, et al. Role of the primary motor cortex in L-DOPA-induced dyskinesia and its modulation by 5-HT1A receptor stimulation. Neuropharmacol 2011;61:753-6.

Buck K, Ferger B. Intrastriatal inhibition of aromatic amino acid decarboxylase prevents L-DOPA-induced dyskinesia: A bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats. Neurobiol Dis 2008;29:210-20.

Katzung BG. Pharmacological management of parkinsonism and other movement disorders. In: Basic and Clinical Pharmacology. 12th ed. Lange Medical Books/McGraw Hill Companies, Inc; 2001.

AHFS drug information 2005. McEvoy GK, ed. Antimuscarinics/ Antispasmodics General Statement. Bethesda, MD: American Society of Health-System Pharmacists; 2005. p. 1229-36.

OECD Guideline for the testing of Chemicals: Repeated Dose 90 d oral toxicity study in rodents; 1998.

Hor SY, Ahmad M, Farsi E, Yam MF, Hashim MA, Lim CP, et al. Safety assessment of methanol extract of red dragon fruit (Hylocereus polyrhizus): Acute and subchronic toxicity studies. Regul Toxicol Pharmacol 2012;63:106-14.

Singh G, Kumar V. Acute and sub-chronic toxicity study of standardized extract of Fumaria indica in rodents. J Ethnopharmacol 2011;134:992-5.

Firenzuoli F, Gori L. Herbal medicine today: clinical and research issueâ€. J Evidence-Based Complementary Altern Med 2007;4:37-40.

Veerappan A, Miyazaki S, Kadarkaraisamy M, Ranganathan D. Acute and subacute toxicity studies of agele Marmelos Corr., an Indian Medicinal plant. Phytomedicine 2004;14:209-15.

Olson H, Betton G, Robinson D, Thomas K, Monro A, Kolaja G, et al. Concordance of toxicity of pharmaceuticals in humans and animals. Regul Toxicol Pharmacol 2000;32:56-67.

Fernanda de A, Claudia A C de A, Marcelo M, Edson L da S. Safety assessment of yerba mate (IIes paraguariensis) dried extract; results of acute and 90 d subchrnoic toxicity studies in rats and rabbits. Food Chem Toxicol 2012;50:328-34.

Lillie L, Temple N, Florence L. Reference values for your normal Sprague-Dawley rats: weight gain, hematology and clinical chemistry. Hum Exp Toxicol 1996;15;612-6.

Weiss D, Wardrop K. Schlam’s Veternary Haematology. 6th edition Wiley-Blackwell, Hoboken, NJ, USA; 2010.

Siva MG, Aragao TP, Vasconcelos CF, Ferreira PA, Andrade BA, Costa IM, et al. Acute and subacute toxicity of cassia occidentalis L. stem and leaf in Wistar rats. J Ethnopharmacol 2011;36:341-6.

Moss DW, Handerson AR, Kachmar JF. In: Fundamentals of Clinical Chemistry. 3rd Eds. (Ed. NW Tietz). Philadelphia: W. B. Saunders Company; 1987. p. 346-421.

Navarro CM, Montilla PM, Martin A, Jimenez J, Utrilla PM. Free radicals scavenger and antihepatotoxic activity of rosmarinus tomentosus. Plant Med 1993;59:312-4.

Fowler BA, Woods JS, Schiller CM. Ultrastructural and biochemical effects of prolonged oral arsenic exposure on liver mitochondria of rats. Environ Health Perspect 1997;19:197-204.

Ojo OA, Oloyede OI, Olarewaju OI, Ojo AB, Ajiboye BO, Onikanni SA. Toxicity studies of the crude Aqueous Leaves extract of Ociumum gratissiumum in Albino Rats. J Enviorn Sci Toxicol Food Technol 2013;6:34-9.



How to Cite

Attar, S. H., D. K. Khatri, J. Sancheti, and A. R. Juvekar. “EVALUATION OF REPEATED DOSE-90-DAY ORAL TOXICITY STUDY OF L-DOPA AND HYOSCINE HYDRBROMIDE COMBINATION IN RATS”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 7, no. 11, Nov. 2015, pp. 241-5, https://innovareacademics.in/journals/index.php/ijpps/article/view/7506.



Original Article(s)